GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

obiltoxaximab   Click here for help

GtoPdb Ligand ID: 13342

Synonyms: Anthim® | ETI-204 | Nyxthracis®
Approved drug
obiltoxaximab is an approved drug (FDA (2016), EMA (2020))
Compound class: Antibody
Comment: Obiltoxaximab is a chimeric IgG1 kappa monoclonal antibody that binds the protective antigen (PA) component of Bacillus anthracis toxin.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. EU EMA (2020)  |  US FDA (2016)
International Nonproprietary Names Click here for help
INN number INN
9825 obiltoxaximab
Synonyms Click here for help
Anthim® | ETI-204 | Nyxthracis®
Database Links Click here for help
Specialist databases
Antibiotic DB Antibiotic DB Database logo Obiltoxaximab (Anthim)
IMGT/mAb-DB 549
Other databases
CAS Registry No. 1351337-07-9 (source: Scifinder)
ChEMBL Ligand CHEMBL3544926
DrugBank Ligand DB05336
GtoPdb PubChem SID 496703312
Search PubMed clinical trials obiltoxaximab
Search PubMed titles obiltoxaximab
Search PubMed titles/abstracts obiltoxaximab